(no subject)
Sep. 28th, 2004 11:59 pmNigerian scientist claims to have working cure for HIV, wants others to review and confirm his findings
A report detailing a controversial "cure" for HIV, as well as a vaccine that prevents against infection with the virus, has been published in a leading scientific journal.
The "cure", or therapeutic vaccine, was developed from the blood of HIV patients. It appeared to clear the deadly virus from 20 people with HIV, claims a report by Jeremiah Abalaka at the Medicrest Specialist Hospital in Gwagwalada, Abuja in Nigeria. A therapeutic vaccine aims to bolster the immune response of a person already infected with a disease, to reduce or stop progression.
Abalaka says his therapeutic vaccine also eliminated antibodies for hepatitis B and C virus from the blood of co-infected HIV-positive patients and improved symptoms of malaria in a handful of patients.
Abalaka, a general surgeon with training in immunology, has tested his cure on almost 4000 HIV positive patients over six years. He also used himself as a guinea pig for both the therapeutic and preventative vaccines.
To test the preventive vaccine, he says he inoculated himself before injecting himself with HIV-positive blood on six separate occasions. He says he did not contract the virus. He then tested the vaccine on about 300 HIV-negative people and says none have yet developed the infection, as far as he knows.
A report detailing a controversial "cure" for HIV, as well as a vaccine that prevents against infection with the virus, has been published in a leading scientific journal.
The "cure", or therapeutic vaccine, was developed from the blood of HIV patients. It appeared to clear the deadly virus from 20 people with HIV, claims a report by Jeremiah Abalaka at the Medicrest Specialist Hospital in Gwagwalada, Abuja in Nigeria. A therapeutic vaccine aims to bolster the immune response of a person already infected with a disease, to reduce or stop progression.
Abalaka says his therapeutic vaccine also eliminated antibodies for hepatitis B and C virus from the blood of co-infected HIV-positive patients and improved symptoms of malaria in a handful of patients.
Abalaka, a general surgeon with training in immunology, has tested his cure on almost 4000 HIV positive patients over six years. He also used himself as a guinea pig for both the therapeutic and preventative vaccines.
To test the preventive vaccine, he says he inoculated himself before injecting himself with HIV-positive blood on six separate occasions. He says he did not contract the virus. He then tested the vaccine on about 300 HIV-negative people and says none have yet developed the infection, as far as he knows.